Medicinal composition

Abstract

A medicinal composition comprises 0.1-90wt% of curcumin, 0.1-90wt% of ginsenoside Rg3 and 0.1-90wt% of Rhizoma Polygoni Cuspidati saponin. The medicinal composition has the advantages of wide pharmacological activity, small side effects, tumor prevention and treatment effects, and synergy and toxicity reduction effects on chemotherapy medicines, and also has blood fat reducing and liver protecting effects.

Description

technical field [0001] The invention relates to the field of tumor treatment, in particular to an antitumor drug combination. Background technique [0002] Tumor is an abnormal lesion formed by the body under the action of various carcinogenic factors, a certain cell in the local tissue loses its normal regulation of its growth at the gene level, resulting in abnormal clonal proliferation. [0003] In recent years, the incidences of lung cancer, primary liver cancer, colorectal cancer, and gynecological malignancies have been increasing year by year. The above malignancies have become one of the biggest threats to human health. Statistics show that since 1996, more than 10 million newly diagnosed cancer patients have been diagnosed worldwide each year, and more than 7 million have died. By the end of 1999, the total number of cancer patients worldwide had exceeded 40 million. By 2000, according to the data from the Information Center of the Ministry of Health of China, the ...

AI Technical Summary

Problems solved by technology

However, surgical treatment has high risk and high recurrence, and middle-advanced lung cancer and lymphocytic cancer cannot be treated surgically at present; while radiotherapy has serious side effects and high risk of recurrence

And above-mentioned treatment usually all can be combined drug therapy, but most of the medicines for treating tumors have great toxic and side effects, long-term use of existing medicines for treating tumors is easy to produce drug resistance

Images